GlassScriptPhysician profile
Aaron Bradley
NPI 1508339151
$8,514.18
in general payments reported to CMS, 2019-2025
33 companies · $1,765 in 2025
The $1,765 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2020: $665 · 2021: $919 · 2022: $1,137 · 2023: $664 · 2024: $1,108 · 2025: $1,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,537.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $2,195.00 | 2019 | |
| Stryker Corporation | $1,856.19 | 2020-2025 | Hoffmann, Ortholoc 3di Crosscheck, Smart Toe |
| Convatec INC. | $618.63 | 2024-2025 | |
| Horizon Therapeutics Plc | $357.67 | 2022-2023 | Krystexxa |
| Smith+Nephew, INC. | $350.72 | 2021-2024 | Grafix Pl |
| Paratek Pharmaceuticals, INC. | $339.72 | 2022-2024 | Nuzyra |
| Cardiovascular Systems INC. | $292.63 | 2020-2023 | Diamondback Peripheral |
| Organogenesis INC. | $289.86 | 2024-2025 | Novachor, Affinity, Simplimax |
| Integra Lifesciences Corporation | $215.49 | 2021-2022 | |
| Boston Scientific Corporation | $215.15 | 2024-2025 | General - Pain Management |
| Amgen INC. | $189.47 | 2024-2025 | Krystexxa |
| Alafair Biosciences, INC. | $161.92 | 2025 | Versawrap |
| Vertex Pharmaceuticals Incorporated | $148.82 | 2025 | |
| Linvatec Corporation | $140.89 | 2025 | Biobrace 23mm, Allograft Tissue, Neospan |
| Averitas Pharma INC. | $120.60 | 2023-2024 | Qutenza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $113.99 | 2025 | |
| Abbvie INC. | $112.90 | 2022 | |
| Medline Industries LP | $111.45 | 2021 | |
| Kerecis Limited | $98.71 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medshape, INC. | $88.42 | 2020 | |
| Axogen | $84.36 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Kci USA, INC. | $71.18 | 2020 | |
| Orthofix Medical, INC. | $60.06 | 2019 | |
| Fortis Surgical, LLC | $50.96 | 2024-2025 | |
| Melinta Therapeutics, LLC | $46.07 | 2020-2021 | |
| Lifenet Health | $31.86 | 2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $28.25 | 2025 | Intellis Adaptivestim |
| Anika Therapeutics, INC. | $23.85 | 2022 | |
| Bioventus LLC | $23.52 | 2023 | Exogen Ultrasound Bone Healing System |
| Curonix LLC | $21.13 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nabriva Therapeutics, Plc | $21.01 | 2021 | |
| Cashflow Solutions, LLC | $17.29 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Ani Pharmaceuticals, INC. | $16.41 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.